Duane Morris LLP advises biotech, biopharma, and pharma companies on matters relating to the development and commercialization of therapeutics, including funding, research and development, clinical trials, and market entry. The firm also represents medical device manufacturers as well as companies in the agriculture and animal health sectors. Its life sciences and medical technologies industry group handles IP, regulatory, and transactional matters affecting product development and commercialization. Dana Ash is a team lead within the group, alongside Frederick Ball in Boston who advises developers, sponsors, manufacturers, CDMOs, contract service providers, food companies, and pharmacies operating in regulated sectors. Michael Harrington represents early and growth-stage companies in tech, life sciences, healthcare, and cleantech industries, while Vicki Norton in San Diego focuses on strategies to counter patent claims and conducts IP due diligence for transactions. Shannon Hampton Sutherland and Miami-based Driscoll Ugarte also serve as team leads within the group. All lawyers mentioned above are based in Philadelphia unless otherwise stated.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘Well-rounded, well-informed, well-educated team. More available to respond and answer matter concerns than other firms’
‘Sima Kulkarni is an exceptional IP attorney, ready to go beyond the expected in client relations and delivery.’
‘Duane Morris assigns a primary contact for each client and then brings in attorneys specializing in certain areas of the law as needed – ensuring the highest quality advice is provided to their clients. Having a primary contact assigned from Duane Morris results in exceptional and efficient client service.’
Key clients
- Monogram Technologies
- Calez Capital
- Allele Biotechnology
- Ocunexus/Inflammx
- Eurofins NSC US, Inc.
- Annovis Bio
- Rijk Zwaan
- International AIDS Vaccine Initiative
- Altimmune, Inc.
- Action Medical Technologies, LLC
Work highlights
Represented a leading orthopedic robotics company in its acquisition by a major medical device manufacturer.
Sued Creative Biolabs Inc. among other co-defendants alleging patent infringement, unfair competition, false advertising, and trademark infringement.
Handled company side diligence support for InflammX’s option agreement with Bausch & Lomb.
Practice head
Dana J. Ash; Frederick R. Ball; Michael S. Harrington; Vicki G. Norton; Shannon Hampton Sutherland; Driscoll R. Ugarte
Other key lawyers
Sima Kulkarni